States Where BCBS Has Dropped GLP-1 Coverage The trend to watch in 2026 is BCBS affiliates pulling back on GLP-1 weight loss drug coverage
, Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies, BMJ , vol
Common side effects include nausea (usually mild), decreased appetite (which aids weight loss), mild digestive changes, and occasional stomach discomfort
Consider decreasing if: Side effects are intolerable despite management strategies, weight loss is faster than 3 pounds per week consistently (which increases gallstone and muscle loss risk), or you have reached your goal weight and want to find the minimum effective maintenance dose
GLP-1 is short for glucagon-like peptide-1 receptor agonists, which work in the brain to impact satiety
I needed professional confirmation as to why my sleep had been plagued by this disorder